Proposed cutoff level of waist circumference in Japanese men: Evaluation by homeostasis model assessment of insulin resistance levels

Internal Medicine

Volumn 51, Issue 16, 2012, Pages 2119-2124

  Kamezaki, Fumihiko ^a   Sonoda, Shinjo ^a   Nakata, Sei ^a   Kashiyama, Kuninobu ^a   Muraoka, Yoshitaka ^a   Okazaki, Masahiro ^a   Tamura, Masahito ^a   Abe, Haruhiko ^a   Takeuchi, Masaaki ^a   Otsuji, Yutaka ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Cutoff level; Homeostasis model assessment of insulin resistance; Japanese men; Metabolic syndrome; Waist circumference

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; DIASTOLIC BLOOD PRESSURE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; MALE; METABOLIC SYNDROME X; PREVALENCE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; WAIST CIRCUMFERENCE;

EID: 84865145487     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7235     Document Type: Article

References (29)

1. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56: 1113-1132, 2010.
2. Takeuchi H, Saitoh S, Takagi S, et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study. Hypertens Res 28: 203-208, 2005.
3. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28: 629-636, 2008.
4. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92: 399-404, 2007.
5. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 375: 181-183, 2010.
6. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645, 2009.
7. Definition and the diagnostic standard for metabolic syndrome. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nihon Naika Gakkai Zasshi (Jpn Soc Intern Med) 94: 794-809, 2005 (in Japanese).
8. Rosenbaum P, Gimeno SG, Sanudo A, Franco LJ, Ferreira SR; Japanese-Brazilian Diabetes Study Group. Analysis of criteria for metabolic syndrome in a population-based study of Japanese- Brazilians. Diabetes Obes Metab 7: 352-359, 2005.
9. Kamezaki F, Sonoda S, Tomotsune Y, Yunaka H, Otsuji Y. Seasonal variation in metabolic syndrome prevalence. Hypertens Res 33: 568-572, 2010.
10. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23: 57-63, 2000.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
12. Kang ES, Yun YS, Park SW, et al. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metabolism 54: 206-211, 2005.
13. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpointsobtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 163: 670-675, 2006.
14. Doi Y, Ninomiya T, Hata J, et al. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study. Stroke 40: 1187-1194, 2009.
15. Peiris AN, Sothmann MS, Hoffmann RG, et al. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 110: 867-872, 1989.
16. Oka R, Kobayashi J, Yagi K, et al. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 79: 474-481, 2008.
17. Hata J, Doi Y, Ninomiya T, et al. The effect of metabolic syndrome defined by various criteria on the development of ischemic stroke subtypes in a general Japanese population. Atherosclerosis 210: 249-255, 2010.
18. Matoba Y, Inoguchi T, Nasu S, et al. Optimal cut points of waist circumference for the clinical diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 31: 590-592, 2008.
19. Nishimura R, Nakagami T, Tominaga M, Yoshiike N, Tajima N. Prevalence of metabolic syndrome and optimal waist circumference cut-off values in Japan. Diabetes Res Clin Pract 78: 77-84, 2007.
20. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36: 54-59, 1987.
21. Hara K, Matsushita Y, Horikoshi M, et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 29: 1123- 1124, 2006.
22. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 366: 1640-1645, 2005.
23. Balkau B, Deanfield JE, Després JP, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116: 1942-1951, 2007.
24. Lofgren I, Herron K, Zern T, et al. Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. J Nutr 134: 1071-1076, 2004.
25. Ohnishi H, Saitoh S, Takagi S, et al. Incidence of insulin resistance in obese subjects in a rural Japanese population: the Tanno and Sobetsu study. Diabetes Obes Metab 7: 83-87, 2005.
26. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 30: 1219-1225, 2007.
27. Matsumoto K, Miyake S, Yano M, et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20: 1562-1568, 1997.
28. Nakamura K, Sakurai M, Miura K, et al. Homeostasis model assessment of insulin resistance and the risk of cardiovascular events in middle-aged non-diabetic Japanese men. Diabetologia 53: 1894-1902, 2010.
29. Tirosh A, Shai I, Afek A, et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med 364: 1315-1325, 2011.